Lacerta Therapeutics Revenue and Competitors

Alachua, FL USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Lacerta Therapeutics's estimated annual revenue is currently $4.8M per year.(i)
  • Lacerta Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Lacerta Therapeutics has 31 Employees.(i)
  • Lacerta Therapeutics grew their employee count by -56% last year.

Lacerta Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CSOReveal Email/Phone
3
VP, Head TechnologiesReveal Email/Phone
4
Senior Director TechnologyReveal Email/Phone
5
DirectorReveal Email/Phone
6
Director Capsid EngineeringReveal Email/Phone
7
Assistant Director, Bioinformatic SciencesReveal Email/Phone
8
Senior Director, AAV manufacturing, mammalian platformReveal Email/Phone
9
Senior Director Preclinical ProgramsReveal Email/Phone
10
Director FinanceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M995%N/AN/A
#2
$1.1M7-30%N/AN/A
#3
$3.7M244%N/AN/A
#4
$4.3M28-3%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.8M50%N/AN/A
#7
$1.1M70%N/AN/A
#8
$2.5M167%N/AN/A
#9
$1.4M9-25%N/AN/A
#10
$0.6M40%N/AN/A
Add Company

What Is Lacerta Therapeutics?

Clinical stage gene therapy company using a constellation of proprietary AAV vector technologies to develop novel treatments for central nervous system and lysosomal storage diseases

keywords:N/A

N/A

Total Funding

31

Number of Employees

$4.8M

Revenue (est)

-56%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lacerta Therapeutics News

2022-03-22 - Lacerta Therapeutics Expands Executive Leadership Team

ALACHUA, Fla.--(BUSINESS WIRE)--Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M31-56%N/A
#2
$5M3210%N/A
#3
$9.5M418%N/A
#4
$12.3M497%N/A
#5
$7M504%N/A